MedPath

Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to Existing Contact Lens Regimens

Not Applicable
Completed
Conditions
Normal Contact Lens Wearers
Interventions
Device: Clear Care
Device: Multi-purpose disinfecting solution
Device: Opti-Free RepleniSH
Registration Number
NCT01294917
Lead Sponsor
Abbott Medical Optics
Brief Summary

Crossover clinical evaluation three contact lens care regimens used for one month with Acuvue Oasys lenses.

Detailed Description

This is a three-arm crossover clinical evaluation of 40 subjects who will use each of three contact lens care regimens for one month with Acuvue Oasys lenses. The subjects will be randomized on the order of solutions used: Investigational MPS, ClearCare, and Opti-Free RepleniSH MPS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Is at least 17 years of age and has full legal capacity to volunteer;
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Has had an ocular examination in the last two years;
  • Is a current soft lens wearer using either two-week or monthly replacement lenses;
  • Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction (either spectacles or contact lenses);
  • Has normal binocular vision (no strabismus, no amblyopia);
  • Has clear corneas and no active ocular disease;
  • Has a distance contact lens prescription between +8.00 diopters (D) to -12.00 D and a successful fit with the study lenses;
  • Has astigmatism less than or equal to -1.00 D;
  • Agrees to wear the study lenses on a daily wear basis.
Exclusion Criteria
  • Has any active ocular disease;
  • Has any clinically significant lid, conjunctival, or corneal abnormalities that may affect a study outcome variable;
  • Has undergone corneal refractive surgery;
  • Has a systemic condition that may affect a study outcome variable;
  • Is using any systemic or topical medications that may affect ocular health;
  • Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  • Is pregnant or lactating;
  • Is participating in any other clinical or research study that may affect a study outcome variable;
  • Currently wears daily disposable lenses or extended wear lenses.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Clear CareClear CarePeroxide-based lens care regimen.
Investigational MPSMulti-purpose disinfecting solutionAMO Investigational MPS.
Opti-Free RepleniSHOpti-Free RepleniSHMulti-purpose disinfecting solution (Alcon).
Primary Outcome Measures
NameTimeMethod
Corneal Staining4 weeks

Corneal staining will be assessed with sodium fluorescein dye on the ocular surface. The cornea is split into 5 sections, each section is evaluated by staining type, depth, and extent is graded on a 0 to 100 scale with higher scores indicating more staining. The possible total range for the total score per eye is 0 to 50,000 (100x100x100=10,000 per section) with values higher than 1200 being clinically relevant.

Secondary Outcome Measures
NameTimeMethod
Subjective Lens Wearing Comfort4 weeks

This will be assessed by a questionnaire on patient-perceived lens comfort and any symptoms of discomfort on a 0 to 100 scale.

Dryness4 weeks

This will be assessed by the tear break-up time on the lens surface, measured in seconds.

Trial Locations

Locations (1)

Centre for Contact Lens Research

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath